Canada markets closed

CSPC Pharmaceutical Group Limited (CVG.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.5600+0.0120 (+2.19%)
At close: 08:05AM CEST
Full screen
Previous Close0.5480
Open0.5600
Bid0.5544 x 1500000
Ask0.5908 x 1500000
Day's Range0.5600 - 0.5600
52 Week Range0.5108 - 0.8750
Volume36,000
Avg. Volume1,283
Market Cap6.521B
Beta (5Y Monthly)0.68
PE Ratio (TTM)9.33
EPS (TTM)0.0600
Earnings DateNov 28, 2024 - Dec 02, 2024
Forward Dividend & Yield0.04 (6.76%)
Ex-Dividend DateOct 31, 2024
1y Target EstN/A
  • Reuters

    FOCUS-China's drugmakers can't sell mRNA shots but haven't quit yet

    China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology, but they face a tough path, crimped by a lack of revenue. Three Chinese companies - Walvax Biotechnology, CSPC Pharmaceutical Group and Stemirna Therapeutics - came up with mRNA vaccines that won limited emergency approvals in Asia. However, Walvax and CSPC are not currently manufacturing three of their China market shots, a China health official told Reuters.